Stem Cell Factor (SCF) can activate Lung Mast cells through CD117 (c-kit) to become more responsive to IgE challenge in vitro. Up regulation of CD63 can be used to track this activation “Heterogeneity in the responses of human lung mast cells to stem cell factor” A. Lewis, J. Wan, B. Baothman, P. N. Monk, S. […]
CD63 upregulation useful to track the activation state of lung Mast cells Read More »
Lower Frequencies of Down-regulatory Fc receptor CD32B on Memory B cells in Rheumatoid Arthritis patients “CD40 Mediates Downregulation of CD32B on Specific Memory B Cell Populations in Rheumatoid Arthritis” Xiaoyu Zhang, Scott E. Strome, et al. (2013 June 15,) J Immunol 190(12): 6015-22. In RA patient samples, CD154 T cell expression levels correlated with
Featured product: Ancell anti-CD105/FITC clone SN6 In these studies, Mesenchymal Stem/Progenitor cells show potential for repairing damaged joint tissue, and restoring liver function. After enriched by sorting, and expansion in culture, the phenotype of resulting stem cell populations are: CD105+, CD29+, CD166+, CD44+, CD45-, CD31-. 1) “Adipose tissue-derived mesenchymal stem cells as a source of
anti-CD105 fluorescent conjugates for phenotypic analysis of Mesenchymal Stem Cells Read More »
Featured product: Ancell Biotinylated mAb cocktail effective for Negative selection of Low Density Granulocyte(LDG) population from Systemic Lupus Erythematosis (SLE) patient blood. “A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs “ M.F. Denny, M.J. Kaplan, et al. (2010) J Immunol 184(6): 3284-3297
Featured Products: F(ab’)2 Fragments of anti-CD64(FcgRI), anti-CD32(FcgRII), and anti-CD16(FcgRIII) for Human Fc Receptor and Immune Complex Research Low Endotoxin and Essentially Free of Intact Antibody, these dimericantibody fragments block Immunoglobulin binding to their repective receptors anti-human CD64 (FcgRI)F(ab’)2 clone 10.1 anti-human CD32 (FcgRII) F(ab’)2 clone 7.3 anti-human CD16 (FcgRIII) F(ab’)2 clone 3G8 Literature Citations Inhibition
CD64 FcγRI, CD32FcγRII, CD16FcγRIII F(ab’)2 Read More »
New human biologically active CD273 ( B7-DC, PD-L2) recombinant protein and other related products now available!
Recombinant CD273-muIg Read More »
SW480 is a primary Colon Epithelial Adenocarcinoma tumor line and SW620 is a metastasized variant of this derived from lymph node. Differential analysis of surface markers may give insight into tumor metastatic potential and/or mechanisms. “Multiplex Flow Cytometry Barcoding and Antibody Arrays Identify Surface Antigen Profiles of Primary and Metastatic Colon Cancer Cell Lines”
Cell Surface Metastatic Markers for Colon Cancer SW480/SW620 Model Read More »
New anti-CD269 (BCMA) antibody available! Purified (with antibiotic) catalog # 269-020 Purified (preservative-free) catalog # 269-020
New anti-CD269 (BCMA) antibody available! Read More »
Ancell is proud to be a sponsor of the 2012 Autumn Immunology Conference in Chicago Nov 16th -Nov 19th. Visit us at booth #18!
Ancell at AIC in Chicago Read More »
“Diversity of Antigen-Specific Responses Induced In Vivo with CTLA-4 Blockade in Prostate Cancer Patients” Kwek S S, L Fong, et al. (Oct 2012) J Immunol 189(7): 3759-3766. “…advanced prostate cancer patients who clinically respond to treatment also develop enhanced Ab responses to a higher number of Ags than nonresponders…” Relevant Ancell Products Anti-CD152(CTLA-4) blocking mAb
